Nemolizumab in moderate-to-severe atopic dermatitis: Randomized, phase II, long-term extension study
The Journal of Allergy and Clinical Immunology | May 16, 2018
Most read this week
The Journal of Allergy and Clinical Immunology | May 16, 2018